Twist Bioscience CorporationTWSTNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank11
3Y CAGR-18.2%
5Y CAGR-33.1%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-18.2%/yr
vs -9.6%/yr prior
5Y CAGR
-33.1%/yr
Recent acceleration
Acceleration
-8.6pp
Decelerating
Percentile
P11
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20254.35-45.1%
20247.92+102.3%
20233.92-50.6%
20227.93-77.9%
202135.96+11.0%
202032.40+185.7%
201911.34-4.4%
201811.86-47.0%
201722.37-79.3%
2016108.20-